Indaptus Therapeutics Inc (INDP)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.7203 -0.0349 (-4.62%) 03/21/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 0.7306 +0.0103 (+1.43%) 18:47 ET
for Fri, Mar 21st, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 15,366 | 16,379 | 14,911 | 7,729 | 3,599 |
| Operating Income | -15,366 | -16,379 | -14,911 | -7,729 | -3,599 |
| Other Income | 344 | 955 | 588 | 18 | 15 |
| Pre-tax Income | -15,022 | -15,424 | -14,323 | -7,711 | -3,584 |
| Net Income Continuous | -15,022 | -15,424 | -14,323 | -7,711 | -3,584 |
| Net Income | $-15,022 | $-15,424 | $-14,323 | $-7,711 | $-3,584 |
| EPS Basic Total Ops | -1.61 | -1.83 | -1.73 | -1.89 | -1.84 |
| EPS Basic Continuous Ops | -1.61 | -1.84 | -1.73 | -1.89 | -1.84 |
| EPS Diluted Total Ops | -1.61 | -1.83 | -1.73 | -1.89 | -1.84 |
| EPS Diluted Continuous Ops | -1.61 | -1.84 | -1.73 | -1.89 | -1.84 |
| EPS Diluted Before Non-Recurring Items | N/A | -1.83 | -1.73 | -1.89 | -16.32 |
| EBITDA(a) | $-15,365 | $-16,377 | $-14,909 | $-7,728 | $-3,598 |